PKM2

What is PKM protein?

PKM (pyruvate kinase M1/2) gene is a protein coding gene which situated on the long arm of chromosome 15 at locus 15q23. This gene encodes a protein involved in glycolysis. The PKM gene can produce two major isoforms through alternative splicing: PKM1 and PKM2. The encoded protein is a pyruvate kinase that catalyzes the transfer of a phosphoryl group from phosphoenolpyruvate to ADP, generating ATP and pyruvate. This protein has been shown to interact with thyroid hormone and may mediate cellular metabolic effects induced by thyroid hormones. This protein has been found to bind Opa protein, a bacterial outer membrane protein involved in gonococcal adherence to and invasion of human cells, suggesting a role of this protein in bacterial pathogenesis. The PKM protein is consisted of 531 amino acids and its molecular mass is approximately 57.9 kDa.

What is the function of PKM protein?

PKM is a key glycolytic enzyme, which mainly plays a role in the glycolysis process of cells. PKM1/2 catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate, and in the process produces ATP. In addition to its metabolic function, PKM1/2 has multiple biological functions, including being involved in cell proliferation, differentiation, and tumorigenesis as a transcription factor for gene expression. Through its non-enzymatic activity, PKM1/2 is able to enter the nucleus and affect the expression of multiple genes, especially in tumor cells. In addition, the activity and expression levels of PKM1/2 are controlled by multiple regulatory mechanisms, including gene transcription, post-translational modification, and subunit assembly, which ensure that cells are able to adjust their metabolic pathways according to energy requirements and metabolic status.

PKM Related Signaling Pathway

PKM (Pyruvate Kinase M), particularly its isoform PKM2, is involved in several signaling pathways that contribute to various cellular processes, including metabolism, cell growth, and tumorigenesis. PKM2 can interact with and phosphorylate the anti-apoptotic protein Bcl-2, and this phosphorylation prevents the binding of ubiquitin E3 ligase to Bcl-2, thereby inhibiting the degradation of Bcl-2 and ultimately inhibiting apoptosis. By affecting the stability of Bcl-2, PKM2 indirectly participates in the signaling of the ubiquitin-proteasome system, which is essential for the degradation and stabilization of proteins within the cell. Studies have shown that dysregulation of mirnas contributes to cancer development by altering the proportion of PKM isoforms expressed.

Fig1. The role of PKM2 in cellular metabolism via the glycolytic pathway. (Danyi Xu, 2019)

PKM Related Diseases

The expression of PKM2 was significantly increased in various tumor cells, and it was involved in the expression, regulation, autophagy and cell cycle progression of tumor cell proliferation related genes. Studies have shown that PKM2 plays a role in the activation of inflammation in diabetic nephropathy, and the activation of PKM2 is related to the activation of inflammatory bodies and the release of inflammatory factors in high glucose environment. PKM1 is expressed in the heart and is associated with cardiac remodeling and function.

Bioapplications of PKM

Due to the role of PKM in a variety of physiological and pathological processes, in-depth study of its structure and function could facilitate drug design and development targeting this enzyme, especially in the development of anti-tumor drugs. In the field of biotechnology, the production of biofuels or bio-based chemicals is enhanced by engineering PKM to improve the glycolysis efficiency of microbial production strains.

Case Study 1: Xin Zhou, 2024

Patients with hypopharyngeal carcinoma (HPC) have a poor prognosis mainly because of lymphatic metastasis. This research aimed to determine the PKM2 role in lymphatic metastasis in HPC and the underlying molecular mechanism contributing to this phenomenon. PKM2 in HPC was studied for its expression and its likelihood of overall survival using TCGA dataset. Western blotting, qRT-PCR, and IHC were employed to confirm PKM2 expression. Methods including gain- and loss-of-function were used to examine the PKM2 role in HPC metastasis in vitro and in vivo. In vitro and in vivo studies also confirmed lymphatic metastasis's mechanism. In vitro research showed that knocking down PKM2 decreased tumor cell invasion, migration, and proliferation while promoting apoptosis and inhibiting epithelial-mesenchymal transition, but overexpressing PKM2 had the reverse effect. Animal studies suggested that PKM2 may facilitate tumor development and lymphatic metastasis.

Fig1. Western blotting analysis of the expression of PKM2 in FaDu cell line.

Fig2. qRT-PCR analysis of mRNA levels of key EMT-related genes in vector and PKM2 groups in vitro.

Case Study 2: Verena Boschert, 2022

The enzyme pyruvate kinase M2 (PKM2) plays a major role in the switch of tumor cells from oxidative phosphorylation to aerobic glycolysis, one of the hallmarks of cancer. Different allosteric inhibitors or activators and several posttranslational modifications regulate its activity. Head and neck squamous cell carcinoma (HNSCC) is a common disease with a high rate of recurrence. To find out more about PKM2 and its modulation in HNSCC, the researchers examined a panel of HNSCC cells using real-time cell metabolic analysis and Western blotting with an emphasis on phosphorylation variant Tyr105 and two reagents known to impair PKM2 activity. The results show that in HNSCC, PKM2 is commonly phosphorylated at Tyrosine 105. Its levels depended on tyrosine kinase activity, emphasizing the importance of growth factors such as EGF (epidermal growth factor) on HNSCC metabolism. Furthermore, its correlation with the expression of CD44 indicates a role in cancer stemness. Cells generally reacted with higher glycolysis to PKM2 activator DASA-58 and lower glycolysis to PKM2 inhibitor Compound 3k, but some were more susceptible to activation and others to inhibition.

Fig3. Western blots of indicated cell lysates with an antibody specific for PKM2 (left) or P-PKM2 Tyr105 (right).

Fig4. EGF stimulation and lapatinib treatment have an impact on levels of P-PKM2 (Tyr105).

PKM2 has several biochemical functions, for example, ATP binding,MHC class II protein complex binding,kinase activity. Some of the functions are cooperated with other proteins, some of the functions could acted by PKM2 itself. We selected most functions PKM2 had, and list some proteins which have the same functions with PKM2. You can find most of the proteins on our site.

PKM2 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with PKM2 here. Most of them are supplied by our site. Hope this information will be useful for your research of PKM2.

ARAF;polg_hcvco;E7;E7;DAPK1;TINF2;ARRB2;ARRB1